- Home
- MLAB vs DGICA Comparison
MLAB vs DGICA Comparison
Compare MLAB & DGICA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLAB
- DGICA
- Stock Information
- Founded
- MLAB 1982
- DGICA 1986
- Country
- MLAB United States
- DGICA United States
- Employees
- MLAB N/A
- DGICA N/A
- Industry
- MLAB Industrial Machinery/Components
- DGICA Property-Casualty Insurers
- Sector
- MLAB Industrials
- DGICA Finance
- Exchange
- MLAB Nasdaq
- DGICA Nasdaq
- Market Cap
- MLAB 680.0M
- DGICA 682.8M
- IPO Year
- MLAB N/A
- DGICA N/A
- Fundamental
- Price
- MLAB $123.84
- DGICA $19.72
- Analyst Decision
- MLAB Hold
- DGICA Hold
- Analyst Count
- MLAB 2
- DGICA 1
- Target Price
- MLAB $140.00
- DGICA $18.00
- AVG Volume (30 Days)
- MLAB 38.2K
- DGICA 119.7K
- Earning Date
- MLAB 05-30-2025
- DGICA 04-24-2025
- Dividend Yield
- MLAB 0.52%
- DGICA 3.70%
- EPS Growth
- MLAB N/A
- DGICA 1206.68
- EPS
- MLAB N/A
- DGICA 2.03
- Revenue
- MLAB $237,747,000.00
- DGICA $993,637,805.00
- Revenue This Year
- MLAB $13.48
- DGICA $5.29
- Revenue Next Year
- MLAB $4.74
- DGICA $5.85
- P/E Ratio
- MLAB N/A
- DGICA $9.69
- Revenue Growth
- MLAB 11.68
- DGICA 5.29
- 52 Week Low
- MLAB $83.68
- DGICA $12.26
- 52 Week High
- MLAB $155.12
- DGICA $20.51
- Technical
- Relative Strength Index (RSI)
- MLAB 58.56
- DGICA 60.30
- Support Level
- MLAB $116.81
- DGICA $19.39
- Resistance Level
- MLAB $128.55
- DGICA $20.03
- Average True Range (ATR)
- MLAB 4.62
- DGICA 0.67
- MACD
- MLAB 1.56
- DGICA 0.05
- Stochastic Oscillator
- MLAB 76.09
- DGICA 67.22
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About DGICA Donegal Group Inc.
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.